[SCIENTX] QoQ TTM Result on 31-Oct-2019 [#1]

Stock
[SCIENTX] SCIENTEX BERHAD
Announcement Date
17-Dec-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2020
Quarter
31-Oct-2019 [#1]
Profit Trend
QoQ- 8.18%
YoY- 33.17%
Quarter Report
Latest QR
Upcoming QR
SCIENTX's Result
SCIENTX's Financial Summary
View:
Show?
TTM Result
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Revenue 3,518,601 3,502,737 3,558,965 3,411,172 3,247,446 3,041,835 2,813,557 16.09%
PBT 544,262 536,647 533,340 493,894 450,588 380,912 356,297 32.67%
Tax -126,236 -128,805 -125,351 -115,881 -104,680 -84,388 -73,456 43.52%
NP 418,026 407,842 407,989 378,013 345,908 296,524 282,841 29.78%
-
NP to SH 390,114 381,464 384,722 360,993 333,697 288,582 276,834 25.72%
-
Tax Rate 23.19% 24.00% 23.50% 23.46% 23.23% 22.15% 20.62% -
Total Cost 3,100,575 3,094,895 3,150,976 3,033,159 2,901,538 2,745,311 2,530,716 14.51%
-
Net Worth 2,563,907 2,434,938 2,356,091 2,308,371 2,225,929 2,123,822 1,843,805 24.60%
Dividend
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Div 118,651 103,113 102,457 102,457 102,457 99,823 97,785 13.77%
Div Payout % 30.41% 27.03% 26.63% 28.38% 30.70% 34.59% 35.32% -
Equity
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Net Worth 2,563,907 2,434,938 2,356,091 2,308,371 2,225,929 2,123,822 1,843,805 24.60%
NOSH 515,876 515,876 515,876 515,261 515,261 515,261 489,233 3.60%
Ratio Analysis
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
NP Margin 11.88% 11.64% 11.46% 11.08% 10.65% 9.75% 10.05% -
ROE 15.22% 15.67% 16.33% 15.64% 14.99% 13.59% 15.01% -
Per Share
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
RPS 682.06 678.99 690.32 662.03 630.25 597.25 575.28 12.03%
EPS 75.62 73.94 74.62 70.06 64.76 56.66 56.60 21.32%
DPS 23.00 20.00 20.00 19.88 19.88 19.60 20.00 9.77%
NAPS 4.97 4.72 4.57 4.48 4.32 4.17 3.77 20.24%
Adjusted Per Share Value based on latest NOSH - 515,261
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
RPS 226.82 225.80 229.42 219.90 209.34 196.09 181.37 16.09%
EPS 25.15 24.59 24.80 23.27 21.51 18.60 17.85 25.70%
DPS 7.65 6.65 6.60 6.60 6.60 6.43 6.30 13.83%
NAPS 1.6528 1.5696 1.5188 1.4881 1.4349 1.3691 1.1886 24.60%
Price Multiplier on Financial Quarter End Date
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Date 30/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 -
Price 9.10 8.30 9.05 9.20 8.42 8.55 8.80 -
P/RPS 1.33 1.22 1.31 1.39 1.34 1.43 1.53 -8.92%
P/EPS 12.03 11.22 12.13 13.13 13.00 15.09 15.55 -15.73%
EY 8.31 8.91 8.25 7.62 7.69 6.63 6.43 18.66%
DY 2.53 2.41 2.21 2.16 2.36 2.29 2.27 7.50%
P/NAPS 1.83 1.76 1.98 2.05 1.95 2.05 2.33 -14.88%
Price Multiplier on Announcement Date
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Date 18/09/20 23/06/20 11/03/20 17/12/19 26/09/19 26/06/19 19/03/19 -
Price 9.50 8.77 8.92 9.53 8.89 8.56 8.46 -
P/RPS 1.39 1.29 1.29 1.44 1.41 1.43 1.47 -3.66%
P/EPS 12.56 11.86 11.95 13.60 13.73 15.11 14.95 -10.97%
EY 7.96 8.43 8.37 7.35 7.28 6.62 6.69 12.29%
DY 2.42 2.28 2.24 2.09 2.24 2.29 2.36 1.68%
P/NAPS 1.91 1.86 1.95 2.13 2.06 2.05 2.24 -10.08%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment